Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Pipeline
Interphex Showcase 2010.

Pharmaceutical Technology
Volume 34, Issue 4, pp. 128-135



Dry-material feeder
The PureFeed AP-300 dry-material feeder was designed specifically for pharmaceutical processes. Users can disassemble the device quickly and easily. The machine includes a dual-arm agitation system for versatility in material handling. Its disposable and recyclable EPDM feed hopper complies with US Food and Drug Administration regulations. Schenck AccuRate, Whitewater, WI http://www.accuratefeeders.com/ tel. 888.232.4828



Top-entering agitators
The PharMix Series 3000 and 4000 top-entering agitators are specifically designed for demanding pharmaceutical and biotechnology mixing applications. The units' robust shaft designs run in free air for cleaning in place and eliminate the need for stabilizing rings. Each agitator comes with a complete prevalidation documentation package. DCI, St. Cloud, MN http://www.dciinc.com/ tel. 320.252.8200



Double rotary tablet press
Fette's 3200i double rotary tablet press is suitable for large to medium-sized nutritional batches. The press's segment technology helps increase productivity for single-layer and double-layer tablets.The unit's exchangeable segment turrets simplify cleaning, increase yield, and speed format change. The device also enables automatic process monitoring. Fette America, Rockaway, NJ http://www.fetteamerica.com/ tel. 973.586.8722



Sterile connector
The 1-in. Pure-Fit SC sterile connector is designed with the same features as Saint-Gobain's other connectors, but in a large, versatile size for great flow volume. The silicone valve design allows easy assembly, and the patented Pure-Fit SIB technology is designed to ensure a smooth inner bore. Saint-Gobain Performance Plastics, Clearwater, FL http://www.biopharm.saint-gobain.com/ tel. 800.541.6880


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here